50 related articles for article (PubMed ID: 38428701)
1. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma.
Assal RA; Elemam NM; Mekky RY; Attia AA; Soliman AH; Gomaa AI; Efthimiadou EK; Braoudaki M; Fahmy SA; Youness RA
Transl Oncol; 2024 Jul; 45():101961. PubMed ID: 38631259
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs 0064286 and 0000475: Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
El Sharkawi FZ; Awad MS; Elagawy W; Al Sawaf HA; Taha H
Asian Pac J Cancer Prev; 2021 Sep; 22(9):3039-3044. PubMed ID: 34582677
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CircRNAs in regulating The "New Generation of Cancer Hallmarks": A Special Depiction on Hepatocellular Carcinoma.
Dawoud A; Elmasri RA; Mohamed AH; Mahmoud A; Rostom MM; Youness RA
Crit Rev Oncol Hematol; 2024 Apr; 196():104312. PubMed ID: 38428701
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer.
Shen H; Liu B; Xu J; Zhang B; Wang Y; Shi L; Cai X
J Hematol Oncol; 2021 Aug; 14(1):134. PubMed ID: 34461958
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy.
Abaza T; El-Aziz MKA; Daniel KA; Karousi P; Papatsirou M; Fahmy SA; Hamdy NM; Kontos CK; Youness RA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003674
[TBL] [Abstract][Full Text] [Related]
6. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.
Sun JY; Zhang XY; Cao YZ; Zhou X; Gu J; Mu XX
J Cell Mol Med; 2020 May; 24(10):5438-5445. PubMed ID: 32281724
[TBL] [Abstract][Full Text] [Related]
8. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
